Skip to main content
Article thumbnail
Location of Repository

Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences

By Georg Laufer, Jens Mayer, Benedikt F Mueller, Nikolaus Mueller-Lantzsch and Klemens Ruprecht
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2007). A: Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MSassociated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol
  2. (2003). A: In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis.
  3. (2000). Alliel PM: Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis?
  4. (2002). BLAT – the BLAST-like alignment tool. Genome Res
  5. (2007). C: Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis. AIDS Res Hum Retroviruses
  6. (2004). C: Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci
  7. (2006). C: Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. AIDS Res Hum Retroviruses
  8. (1985). Calendar A, de The G: Antibodies to HTLV-1 in patients with tropical spastic paraparesis. The Lancet
  9. (2002). Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W. Mol Biol Evol
  10. (2005). Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis.
  11. (2000). Cosset FL: An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.
  12. (2004). CV: Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun
  13. (1980). de Crombrugghe B: Sequence rearrangement and duplication of double stranded fibronectin cDNA probably occurring during cDNA synthesis by AMV reverse transcriptase and Escherichia coli DNA polymerase I. Nucleic Acids Res
  14. (2008). DJ: Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev
  15. (1992). EN: Temperature-dependent template switching during in vitro cDNA synthesis by the AMVreverse transcriptase. Nucleic Acids Res
  16. (2001). et al.: Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology
  17. Evolutionary aspects of human endogenous retroviral sequences (HERVs) and disease.
  18. (2007). Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination. Retrovirology
  19. (2008). Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics
  20. (2004). F: Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation. Mol Biol Evol
  21. (2004). FS: Identification of endogenous retroviral reading frames in the human genome. Retrovirology
  22. (1998). H: Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet
  23. (2007). H: Elevated levels of human endogenous retrovirusW transcripts in blood cells from patients with first episode schizophrenia. Genes Brain Behav
  24. (2005). High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol
  25. (1991). HJ: Just another dubious virus in cells from a patient with multiple sclerosis? Lancet
  26. (2008). Human endogenous retrovirus family HERVK(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21. J Virol
  27. (2005). Human endogenous retroviruses: from infectious elements to human genes. Cytogenet Genome Res
  28. (2005). Leib-Mosch C: Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray.
  29. (1997). Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes.
  30. (2004). Meese E: Human endogenous retrovirus HERVK(HML-2) proviruses with Rec protein coding capacity and transcriptional activity. Virology
  31. (1999). Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family.
  32. (1999). Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology
  33. (1997). Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA
  34. (2005). MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus.
  35. (2008). Mueller-Lantzsch N: Endogenous retroviruses and cancer. Cell Mol Life Sci
  36. (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res
  37. (2000). Paranhos-Baccala G: Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family. AIDS Res Hum Retroviruses
  38. (2006). PN: The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses.
  39. (2002). Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution. Genome Res
  40. (1999). Progress in determining the causes and treatment of multiple sclerosis. Nature
  41. (2005). Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res
  42. Retroelements and the human genome: new perspectives on an old relation.
  43. (2006). Rieckmann P: Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
  44. (1990). S: DNA recombination during PCR. Nucleic Acids Res
  45. (1983). Scheinberg L: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol
  46. (1991). Seigneurin JM: Isolation of retrovirus from patients with multiple sclerosis. Lancet
  47. (1989). Seigneurin JM: Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Research in Virology
  48. (2002). Sotgiu S: Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology
  49. (1998). Stimulation and suppression of PCR-mediated recombination.
  50. (2005). Syncytin and the role of endogenous retroviral proteins in demyelination. Mult Scler
  51. (1990). Template switching by reverse transcriptase during DNA synthesis.
  52. (2004). The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology. Proc Natl Acad Sci USA
  53. (2007). The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes.
  54. (2009). The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease.
  55. (2006). Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology
  56. (1998). VK: Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.